#Albumin Market

[mordormr]

Exploring the Albumin Market: Growth Drivers, Trends, and Future Opportunities

The Albumin Market is projected to be valued at USD 7.27 billion in 2024 and is anticipated to reach USD 10.56 billion by 2029, with a compound annual growth rate (CAGR) of 7.76% over the forecast period from 2024 to 2029.

Key Growth Drivers in the Albumin Market

Rising Prevalence of Chronic Diseases The growing number of patients suffering from chronic conditions such as liver disease, kidney disorders, and cardiovascular diseases is a major driver of the albumin market. Albumin is widely used in the treatment of hypoalbuminemia (low levels of albumin in the blood), a condition often seen in these patients. As healthcare systems around the world face increasing pressure to manage these diseases, the demand for albumin-based therapies continues to rise.

Expanding Applications in Drug Delivery and Biotechnology Albumin’s versatility extends beyond its traditional medical applications. It is increasingly being used in drug delivery systems and biotechnology, where it enhances the efficacy and bioavailability of drugs. For instance, albumin-bound drugs are gaining traction for their ability to improve drug stability and control the release of therapeutics in the body. As research continues to explore new ways to harness albumin in drug formulation, the market is expected to see further growth.

Growth in Plasma-Derived Therapies Albumin, a major component of human plasma, is a key player in the plasma-derived therapy market. These therapies are widely used for conditions such as hemophilia, immune deficiencies, and other blood disorders. The increased demand for plasma products has led to significant investments in plasma fractionation and albumin production, further driving market growth.

Increased Use in Clinical Trials and Research Albumin’s potential in new and emerging therapeutic areas is gaining attention. In recent years, the protein has been utilized in clinical trials aimed at developing treatments for cancer, infectious diseases, and autoimmune disorders. As the research pipeline for albumin-based therapies expands, so does the market’s potential for growth.

Market Trends Shaping the Albumin Industry

Technological Advancements in Albumin Production Innovations in the production and purification of albumin are playing a pivotal role in shaping the market. Recombinant albumin production is one such advancement that offers an alternative to plasma-derived albumin, ensuring a more consistent and scalable supply of the protein. This technology is especially appealing to pharmaceutical companies seeking high-purity albumin for use in sensitive applications, such as drug delivery.

Rising Demand in Emerging Markets Developing countries in regions such as Asia-Pacific and Latin America are witnessing an increasing demand for albumin, particularly in healthcare and biopharmaceutical industries. The growing adoption of albumin-based therapies in these regions, coupled with improved healthcare infrastructure and rising healthcare expenditure, is expected to fuel market growth.

Regulatory Approvals and Standards As the demand for albumin grows, regulatory bodies across the globe are focusing on setting standards for its production and use. In regions like North America and Europe, strict regulations surrounding the safety and efficacy of albumin products are ensuring high-quality standards in the industry. This focus on regulation and quality assurance is expected to foster consumer trust and drive market expansion.

Future Opportunities in the Albumin Market

The albumin market offers several promising growth opportunities, particularly as research and development in biopharmaceuticals expand. Some of the most exciting opportunities include:

Expanding Albumin's Role in Regenerative Medicine: Research into albumin’s use in stem cell therapy and tissue engineering is opening up new possibilities for the protein in regenerative medicine. Albumin’s ability to serve as a scaffold for cell growth makes it an ideal candidate for innovative therapies aimed at repairing damaged tissues and organs.

Novel Albumin-Based Drug Formulations: As drug delivery technologies evolve, the potential for albumin-based formulations to improve the stability and bioavailability of drugs is becoming more evident. The development of novel albumin-bound therapeutics, particularly in oncology, offers significant growth potential for the market.

Global Plasma Collection Expansion: As the need for plasma-derived products, including albumin, grows, expanding global plasma collection networks will be critical. Increasing plasma donation centers and advancing fractionation technology will support the rising demand for albumin, particularly in underserved regions.

Conclusion

The global albumin market is set to experience sustained growth, driven by its expanding role in medical therapies, biotechnology, and drug delivery. With the rising prevalence of chronic diseases, innovations in production technology, and increasing global demand for plasma-derived therapies, the market is poised for long-term expansion. According to Mordor Intelligence, the future holds immense potential for growth, particularly as new applications for albumin emerge and global healthcare needs evolve. As research continues to unlock the full potential of albumin, the market is likely to play a crucial role in the future of healthcare and biotechnology.

For a detailed overview and more insights, you can refer to the full market research report by Mordor Intelligence: https://www.mordorintelligence.com/industry-reports/albumin-market

[blog-site-for-market-research]

Market Share Analysis of Albumin Market Services

Market Overview –

The albumin market revolves around the production, distribution, and utilization of albumin, a vital protein found in blood plasma. Human serum albumin (HSA) and bovine serum albumin (BSA) are the two primary types used in various medical, pharmaceutical, and biotechnological applications. Albumin serves diverse functions in the body, including maintaining osmotic pressure, transporting hormones and drugs, and regulating pH levels.

The albumin (as excipient) market size was estimated to be around USD 0.9 billion in 2022 and is expected to increase at a compound yearly growth rate (CAGR) of 5.9% from USD 0.95 billion in 2023 to USD 1.46 billion by 2032.

The albumin market centers on the production and distribution of albumin, a vital protein found in blood plasma that performs various functions such as maintaining osmotic pressure, transporting molecules, and regulating pH levels. Albumin is commonly used in pharmaceuticals, diagnostics, and research applications.

The albumin market, particularly emphasizing macroaggregated albumin, is witnessing steady growth. As a vital component in various medical applications, including diagnostics and therapeutics, albumin's demand remains high. Macroaggregated albumin plays a crucial role in nuclear medicine, particularly in lung perfusion scans. This specialized application contributes to the market's continued expansion and innovation.

Market growth is propelled by the increasing demand for albumin in medical treatments, including volume expansion therapy, drug delivery, and plasma protein replacement therapy for patients with liver diseases, burns, and other medical conditions. Albumin is also utilized in diagnostic tests and research experiments due to its unique properties and versatility.

Technological advancements and innovations in albumin purification, formulation, and storage methods are shaping the market, offering high-purity, stable, and cost-effective albumin products. From chromatography techniques and virus inactivation methods to lyophilization and nanotechnology-based formulations, these advancements improve albumin quality, safety, and shelf-life, meeting the diverse needs of healthcare providers and researchers.

Moreover, the COVID-19 pandemic has underscored the importance of albumin in critical care settings, as healthcare systems face challenges such as fluid resuscitation, hypoalbuminemia, and cytokine storms in severely ill patients. Albumin plays a crucial role in stabilizing blood volume, supporting organ function, and modulating inflammatory responses, driving market growth and innovation in the medical field.

However, challenges such as supply chain disruptions, regulatory constraints, and pricing pressures pose obstacles to market growth. Addressing these challenges requires collaboration between albumin manufacturers, regulatory agencies, and healthcare providers to ensure product safety, quality, and accessibility for patients in need.

Overall, the albumin market presents significant opportunities for innovation and collaboration to improve patient care and advance medical research. By investing in research, technology, and manufacturing capabilities, stakeholders can drive continued growth and advancement in the albumin market and contribute to better healthcare outcomes for individuals worldwide.

Segmentation –

The global albumin (as excipient) market is segmented based on type, application, end user, and region.

The global albumin (as excipient) market, by type is segmented into human serum albumin, bovine serum albumin, and recombinant albumin. The human serum albumin segment is anticipated to hold the largest market share owing to the increasing cases of chronic conditions such as, cardiac disorders, infectious diseases, and others.

Based on application, the market is segmented into drug formulation, drug delivery, vaccines, medical device coating, culture media & stabilizers, diagnostics, in vitro fertilization, and others.

Based on end user, the market is segmented into pharmaceutical & biotechnology industry, academic and research institutes, and others.

Regional Analysis –

Regional analysis of the albumin market reveals diverse trends and dynamics across different parts of the world. In North America, particularly in the United States and Canada, the albumin market is significant due to factors such as a large aging population, well-established healthcare infrastructure, and high demand for albumin in various medical applications.

The region witnesses a growing use of albumin in critical care settings, including treatment of shock, burns, and liver disease, as well as in therapeutic formulations and research. Europe showcases a mature albumin market, with countries like Germany, the UK, and France leading in terms of consumption and production.

The region benefits from stringent regulatory standards ensuring product quality and safety, along with a strong presence of leading albumin manufacturers. In the Asia-Pacific region, countries like China, India, and Japan are emerging as key players in the albumin market, driven by increasing healthcare expenditure, growing prevalence of chronic diseases, and expanding pharmaceutical and biotechnology sectors. Latin America exhibits significant growth potential in the albumin market, fueled by improving healthcare infrastructure and rising demand for blood products.

The Middle East and Africa region also experience a steady increase in albumin consumption, supported by expanding healthcare access and a growing focus on medical advancements. Understanding these regional dynamics is essential for albumin manufacturers and suppliers to develop targeted strategies, ensure market access, and meet the specific needs of diverse customer bases worldwide.

Key Players –

Albumin companies include Albumedix A/S, Albumin Therapeutics, LLC Baxalta Incorporated, Baxter International Inc., Biotest AG, CSL Behring LLC, China Biologic Products Inc., Grifols International, HiMedia Laboratories Pvt. Ltd., among others.

Related Reports –

Medical Tourniquets

Forensic Swab

Ascites

Intraoperative Neurophysiological Monitoring

For more information visit at MarketResearchFuture

[soumyafwr]

https://app.socie.com.br/read-blog/134576_albumin-market-size-analysis-and-forecast-2031.html

Albumin Market Size, Analysis and Forecast 2031

[meghanester]

Albumin Market Size, Growth with a CAGR of ~6% During 2023-2035 and Attain ~USD 10 Billion by 2035

Research Nester’s recent market research analysis on “Albumin Market: Global Demand Analysis & Opportunity Outlook 2035” delivers a detailed competitors analysis and a detailed overview of the global albumin market in terms of market segmentation by type, grade, application, and by region.

Rise in the Number of Heart Operation Performed in the World to Promote Global Market Share of Albumin

The global albumin market is estimated to grow majorly on account of the increasing prevalence of diseases, that affects human organs and requires the surgery. For instance, Patients undergoing cardiac surgery may incur severe blood loss, demanding the replacement of electrolytes and blood-related materials. Therefore, rise in the number of cardiac surgeries will drive the demand for albumins. Every year, roughly 2 million individuals worldwide receive open-heart surgery in order to treat various cardiovascular conditions. On the other hand, it is expected that in the coming few years, over 50 million adults in the world will be suffering from chronic liver disease, since it occurrence rate has increase from 4.5% to 9.5% in the world wide population. Albumin is employed as a component in the removal of excess fluid from the abdomen in liver illnesses.

Get a Sample PDF Brochure: https://www.researchnester.com/sample-request-5035

Besides this, various development has taken place in albumin, which makes it suitable for treating or aiding the treatment of a wide range of diseases. For instance, some researchers have suggested in COVID-19 patients if albumin serum is injected at low levels. It helps identify patients who are at high risk of developing pneumonia or respiratory failure and patients who require longer stays at the hospital. Furthermore, the rising popularity of plant-based albumin has significant drive the industry’s expansion. Plant-based albumins enable adaptation and change in function. As a result, scientists are attempting to create novel plant-based albumins through genetic engineering or by optimizing natural sources.

Some of the major growth factors and challenges that are associated with the growth of the global albumin market are:

Growth Drivers:

Surge in the Cardiovascular Surgeries

Rising Use of Albumins in the Research and Development of Drug Delivery Systems

Challenges:

Many people have shown allergic reactions towards albumin and there are strict regulatory policies for approving the use of albumin are some of the major factors anticipated to hamper the global market size of albumin. Individuals with known allergies to albumin or other proteins are more prone to experience allergic responses. The symptoms range from, skin rashes to serious effects, like breathlessness, chest pain, and others. On the other hand, there are many substitutes present in the market which is also expected to impede market growth. Albumins face competition from various alternative products and technologies in different applications. Some of the tough competitors are synthetic polymers, hydroxyethyl starch (HES), recombinant proteins, human serum-derived proteins, nanoparticles, and liposomes.

Request for customization @ https://www.researchnester.com/customized-reports-5035

On the basis of application, the global albumin market is segmented into drug formulation & vaccines, therapeutics, research. The therapeutics segment is anticipated to bring in the most revenue by the end of 2035, with a considerable CAGR over the forecast period. The growth of the segment is credited to growing incidents involving severe burns and other injuries. Albumin is utilized as a plasma expander to restore and maintain intravascular volumes, which is lost due to severe burns. Furthermore, based on type, the market is further fragmented into recombinant albumin, human serum albumin, bovine albumin. Out of all, human serum albumin has shown tremendous growth and will be growing notably in the forecast period. The rising spending on the research and development of new drugs has boosted the demand for human serum albumin,

Furthermore, by the end of 2035, Europe is expected to control a significant share of the market.  Improved understanding of the role of albumin in various conditions and the development of innovative therapies have increased the utilization of albumin in Europe. The advancements in medical technology and practices have expanded the application of albumins in healthcare. On the other hand, the rising prevalence of liver diseases, such as cirrhosis, hepatitis, and liver failure are also anticipated to boost the market growth in the region.

Obtain this Report @ https://www.researchnester.com/reports/albumin-market/5035

This report also provides the existing competitive scenario of some of the key players of the global albumin market which includes company profiling of Octapharma AG, Bio Med International Pvt. Ltd., Baxter, Apotex Inc., Novozymes, Mitsubishi Tanabe Pharma America Inc., Merck KGaA, Akron Biotech, Thermo Fisher Scientific, and Grifols, S.A

About Us

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.

Contact for more Info:

AJ Daniel

Email: info@researchnester.com

U.S. Phone: +1 646 586 9123

U.K. Phone: +44 203 608 5919

[wemarketresearchreport]

albumin market was worth USD 0.81 billion in 2021 and is poised to accumulate a valuation of USD 1.7 billion by 2030, registering a CAGR of 6.3% over the forecast duration of 2022-2030.

[marketresearchreports1]

Rising adoption of recombinant albumin-based drug delivery systems by pharmaceutical and biotechnology companies is one of the key factors driving the albumin (as excipient) market. For instance, in 2014, Novozymes Biopharma DK A/S announced that its albumin-based VELTIS technology is used by GlaxoSmithKline plc in the manufacturing of type II diabetes drug (Tanzeum and Eperzan) in Europe.

[businessindustry]

Albumin & Creatinine Tests Market Unlimited Opportunities for New Companies, Forecast to 2024-2032

The Reports and Insights, a leading market research company, has recently releases report titled “Albumin & Creatinine Tests Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032.” The study provides a detailed analysis of the industry, including the global Albumin & Creatinine Tests Market Size share, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights:

How big is the Albumin & Creatinine Tests Market?

The albumin and creatinine tests market size reached US$ 1,284.5 million in 2023. Looking forward, Reports and Insights expects the market to reach US$ 4,344.9 million in 2032, exhibiting a growth rate (CAGR) of 14.5% during 2024-2032.

What are Albumin & Creatinine Tests?                                                                                                                                                                            

The albumin and creatinine tests are standard methods for evaluating kidney function and detecting early signs of kidney damage. The albumin test measures the levels of albumin, a blood protein, while the creatinine test measures creatinine, a muscle waste product. Normally, the kidneys prevent albumin from entering the urine and maintain stable creatinine levels. However, if kidney function is impaired, albumin may appear in the urine, and creatinine levels may increase. These tests are typically conducted together, either as a urine test (albumin-to-creatinine ratio) or a blood test, providing a comprehensive assessment of kidney health.

Request for a sample copy with detail analysis: https://www.reportsandinsights.com/sample-request/2045

What are the growth prospects and trends in the Albumin & Creatinine Tests industry?

The albumin and creatinine tests market growth are driven by various factors and trends. The market for albumin and creatinine tests is expanding as kidney disorders become more prevalent and early diagnostic tools are increasingly sought after. These tests play a critical role in assessing kidney function and identifying conditions like chronic kidney disease. Market growth is driven by factors such as an aging population, lifestyle shifts leading to kidney-related issues, and advancements in diagnostic technology. Moreover, the growing emphasis on preventive healthcare and the significance of routine health screenings are also contributing to the increased demand for albumin and creatinine tests. Hence, all these factors contribute to albumin and creatinine tests market growth.

What is included in market segmentation?

The report has segmented the market into the following categories:

By Type

Urine Albumin Tests

Urine Creatinine Tests

Glycated Albumin

Micro Albumin Test

Blood and Serum Creatinine Tests

By Product

Cartridges

Cartridges for POC Analyzers

Cartridges for Table-Top Analyzers

Dipsticks Kits

Analyzers

Reagents

Other Consumables

By Application

Kidney Disease Diagnosis

Diabetes

High Blood Pressure

Kidney Screening

Others

By End-User

Hospitals Clinics

Diagnostic Laboratories

Research Laboratories Institutes

By Region

North America

United States

Canada

Europe

Germany

United Kingdom

France

Italy

Spain

Russia

Poland

Benelux

Nordic

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

ASEAN

Australia New Zealand

Rest of Asia Pacific

Latin America

Brazil

Mexico

Argentina

Middle East Africa

Saudi Arabia

South Africa

United Arab Emirates

Israel

Rest of MEA

Who are the key players operating in the industry?

The report covers the major market players including:

Abbott

Roche Diagnostics

Fujifilm Wako Pure Chemical Corporation

Nova Biomedical

Ortho Clinical Diagnostics

Danaher

Siemens Healthcare Gmbh

Promocell Gmbh

Sysmex Corporation

Thermos Fisher Scientific Holdings, Inc.

View Full Report: https://www.reportsandinsights.com/report/Albumin & Creatinine Tests-market

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

Reports and Insights consistently mееt international benchmarks in the market research industry and maintain a kееn focus on providing only the highest quality of reports and analysis outlooks across markets, industries, domains, sectors, and verticals. We have bееn catering to varying market nееds and do not compromise on quality and research efforts in our objective to deliver only the very best to our clients globally.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact Us:

Reports and Insights Business Research Pvt. Ltd. 1820 Avenue M, Brooklyn, NY, 11230, United States Contact No: +1-(347)-748-1518 Email: sales@reportsandinsights.com Website: https://www.reportsandinsights.com/ Follow us on LinkedIn: https://www.linkedin.com/company/report-and-insights/ Follow us on twitter: https://twitter.com/ReportsandInsi1

[pranalipawarshinde]

Albumin & Creatinine Tests Market – In Depth Insight Analysis to 2033

“Global Insight Services offers unparalleled market intelligence and strategic consulting services to businesses worldwide. Our expertise spans across various industries, including healthcare, technology, and consumer goods, providing comprehensive analysis and actionable insights. By leveraging advanced data analytics and in-depth market research, we empower our clients to make informed decisions, identify growth opportunities, and stay ahead of the competition”.

Global Albumin & Creatinine Tests Market is expected to reach $3.6 bn by 2031 growing at a CAGR of 14.7% between 2021 and 2031.

The urine albumin to creatinine ratio test is a common way to screen for high levels of albumin, which is known as albuminuria. This screening is most often done on people who have a greater risk of kidney disease comprising people with diabetes, high blood pressure, or a family history of kidney problems. Screening may also be recommended in older adults and people in some racial and ethnic groups. Screening for kidney disease may combine a urine albumin test with another kidney function test, known as an estimated glomerular filtration rate (eGFR) test, that assesses how well the kidneys are filtering the blood.

View The Full Report Here –https://www.globalinsightservices.com/reports/albumin-creatinine-tests-market

Market Drivers

Rising prevalence of kidney disorders

Kidney disease is one of the major causes of death worldwide. Such cases—comprising multiple kidney treatments—require the continuous monitoring of components such as creatinine and albumin and their ratios, for which multiple urine analysis products and techniques are utilized. Urine analysis has extensive applications in the diagnosis and management of kidney diseases. Biochemical urine analysis enables clinicians to assess the level of chemical compounds (such as creatinine, urobilinogen, bilirubin, ketones, and glucose) in the urine. Atypical levels of these compounds in the urine indicate chronic kidney diseases, acute kidney injuries, and acute renal failure. So, the growing incidence of kidney diseases will be the primary growth driver for this market, as it will ensure sustained demand for albumin and creatinine tests.

Market Opportunity

Integrated and automated systems for overall urine analysis

The combination of automated urine sediment and urine biochemical analysis in one system allows rapid and easy urine analysis. Currently, standalone automated urine sediment analyzers help standardize sediment & biochemical analysis with minimum operator interference and enable the fast analysis of urine samples. Such integrated systems have a high potential in the automated devices market and can help large hospitals and diagnostic labs to manage their workloads ecologically. Owing to that, this area has been identified as an opportunity in the market.

Market Restraints

High cost of automated analyzers

Most small hospitals and clinics with lower workloads still prefer semi-automated devices or manual analysis. Automated devices are primarily used by large hospitals with higher workloads; so, the revenue generation can justify the costs incurred in installing automated analyzers. This makes it difficult for automated analyzers to penetrate the market, specifically in developing economies, which is a major restraint factor to market growth.

Unlock Growth Potential in Your Industry – Get Your Sample Report Now-https://www.globalinsightservices.com/request-sample/GIS10235

Impact of COVID-19 on Albumin & Creatinine Tests Market

Acute Renal Failure (ARF) is generally detected and confirmed by increased creatinine levels in the urine, coupled with a sudden drop in the urine output. Adding to that, the rise in and high rate of hypoalbuminemia caused by COVID-19 (coupled with the rising geriatric population and other factors) is likely to increase the cases of AKI/ARF and thus support the market growth during the early half of the projection period.

Market Segments

By Product

Dipsticks & Kits

Analyzers

Cartridges

Cartridges for POC Analyzers

Cartridges for Table-Top Analyzer

Reagents & Other Consumables

By Type

Urine Tests

Urine Albumin Tests

Urine Creatinine Tests

Glycated Albumin

Blood & Serum Creatinine Tests

By End User

Hospitals & Clinics

Diagnostic Laboratories

Research Laboratories & Institutes

By Region

North America

Europe

Asia Pacific

Rest of the World

Market Players of Global Albumin & Creatinine Tests Market

The key players in the global albumin & creatinine tests market are Thermo Fisher Scientific, Inc., Roche Diagnostics, PromoCell GmbH, Abbott Laboratories, Siemens Healthineers, Danaher Corporation, Sysmex Corporation, Ortho Clinical Diagnostics, Randox Laboratories, FUJIFILM Wako Pure Chemical Corporation, Abbexa Ltd., ACON Laboratories, Inc., Arbor Assays Inc., ARKRAY Global Business Inc., Aviva Systems Biology, Axxora, LLC, BioAssay Systems, Nova Biomedical, Quantimetrix Corporation, RayBiotech Inc., Sekisui Diagnostics PEI Inc., Teco Diagnostics, Tulip Diagnostics, ulti med Products GmbH, and URIT Medical Electronic Co., Ltd. among others.

Buy Now@https://www.globalinsightservices.com/checkout/single_user/GIS10235

 Research Scope

Scope – Highlights, Trends, Insights. Attractiveness, Forecast

Market Sizing – Product Type, End User, Offering Type, Technology, Region, Country, Others

Market Dynamics – Market Segmentation, Demand and Supply, Bargaining Power of Buyers and Sellers, Drivers, Restraints, Opportunities, Threat Analysis, Impact Analysis, Porters 5 Forces, Ansoff Analysis, Supply Chain

Business Framework – Case Studies, Regulatory Landscape, Pricing, Policies and Regulations, New Product Launches. M&As, Recent Developments

Competitive Landscape – Market Share Analysis, Market Leaders, Emerging Players, Vendor Benchmarking, Developmental Strategy Benchmarking, PESTLE Analysis, Value Chain Analysis

Company Profiles – Overview, Business Segments, Business Performance, Product Offering, Key Developmental Strategies, SWOT Analysis.

With Global Insight Services, you receive:

10-year forecast to help you make strategic decisions

In-depth segmentation which can be customized as per your requirements

Free consultation with lead analyst of the report

Infographic excel data pack, easy to analyze big data

Robust and transparent research methodology

Unmatched data quality and after sales service

Contact Us:

Global Insight Services LLC 16192, Coastal Highway, Lewes DE 19958 E-mail: info@globalinsightservices.com Phone: +1-833-761-1700 Website: https://www.globalinsightservices.com/

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

[wellnessextractsblog]

What are the Causes of Hair Loss in Males Explained

Unlocking the Mystery: Understanding Total Protein Albumin and Globulin Levels as Key Factors in Explaining the Causes of Hair Loss in Males. Delve into the intricate relationship between protein levels and hair health, exploring how fluctuations in albumin and globulin impact hair follicles. Gain insights into the physiological mechanisms behind male pattern baldness, shedding light on potential preventative measures and treatments.

[marketinsight12]

The Global Albumin Market size is expected to grow from USD 5.57 billion in 2022 to USD 9.48 billion by 2030, at a CAGR of 7.9% during the forecast period (2023-2030).

Albumin Market - Comprehensive Study Report with Recent Trends | IMR

[shivt123]

Albumin market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 1,364.41 million by 2028 and will grow at a CAGR of 6.00% in the above mentioned forecast period.

[everythingwaschocolateandsugar]

The Global Cardiac Biomarkers Market size was valued at USD 8.42 billion in 2019 and is predicted to reach USD 28.29 billion by 2030, with a CAGR of 11.6% from 2020-2030.

[soumyafwr]

Albumin Market Size, Analysis and Forecast 2031

[meditech-insights]

Global Albumin Market is expected to grow at a healthy CAGR of ~6% by 2026

Albumin is the most abundant circulating protein in the plasma, accounting for more than half of the human plasma protein. Albumin has been usually studied as a protein carrier for drug delivery. They are utilized in a various applications including oncology, diabetes, hepatitis C, hypovolemia, and rheumatoid arthritis.

The Global Albumin Market is expected to grow at a rate of ~6% by 2026. The development of albumin-based nanoparticles for drug delivery, high demand for albumin in R&D activities & clinical trials, rising production of immunoglobulin, growing plasma collection, increased preference for recombinant albumin in drug delivery, increasing awareness about the benefits of albumin, growing usage of albumin as blood volumizer in a condition of shocks & burns, and rise in non-therapeutic applications of albumin as a multifunctional excipient are some of the key factors driving the global albumin market.

Growing Demand for Albumin in Research & Development and Clinical Trials Drives the Global Albumin Market

Malignant, inflammatory, metabolic, and viral diseases are specifically treated and diagnosed with albumin-based therapeutic agents. Considering the commercial success of products that utilise albumin as a drug carrier and the ongoing clinical trials albumin is attracting the interest of researchers, pharmaceutical, and biotechnological companies.

Albumin-Based Nanoparticles Offer Promising Drug Delivery System for Cancer Treatment

Albumin is a versatile biomaterial for the synthesis of nanoparticles. The efficiency of the albumin-based delivery resides in its capacity to improve tumor targeting and accumulation. Additionally, albumin can bind to special receptors overexpressed on cancer cells and enhance nanoparticle binding and internalization.

Explore Premium Report on Albumin Market @ https://meditechinsights.com/global-albumin-market/

Growing Adoption of Recombinant Albumin over Serum-based Albumin for Drug Delivery Fuels the Albumin Market Demand

As regulatory guidelines have driven the need for animal-free options, there has been a decline in the use of serum-derived albumin. Historical risks related to human serum albumin have been eliminated with the availability of recombinant albumin. It also provides a relatively simple solution to traditional formulation strategies and provides a cost-effective, single solution to several stability issues.

The Potential Role of Human Serum Albumin in Covid-19 Patients Boosts the Albumin Market

Albumin downregulates the expression of the ACE2 receptors and has been shown to improve the ratio of arterial partial pressure of oxygen/fraction of inspired oxygen in patients with acute respiratory distress syndrome as soon as 24 hours after treatment and with an effect that persists for at least seven days. Furthermore, researchers who have studied the clinical characteristics of Covid-19 patients have reported that low serum albumin on presentation in COVID-19 infection is associated with a higher incidence of serious outcomes like kidney injury, cardiac injury, and higher mortality, among others.

Key Challenges/ Constraints: Albumin Market

The stringent government regulations, limited reimbursement, rising shift towards serum-free solutions, and side effects associated with the use of albumin are the major factors restraining the growth of the albumin market.

North America Holds the Largest Market Share but APAC is Set to Witness Strongest Growth

The biggest market share for albumin market is held by North America. This can be mainly attributed to the increasing demand for albumin-based R&D activities, the presence of advanced and robust healthcare infrastructure, the rising demand for albumin in various non-therapeutics applications, and the presence of market key players in the region.

Companies Adopt both Organic & Inorganic Growth Strategies to Increase their Market Share

To gain market share, players in the albumin market are adopting both organic and inorganic growth strategies, such as collaborations, acquisitions, and expansions.

For instance,

In April 2022, Apotex Corp. announced the release of its Paclitaxel protein-bound particles for injection (albumin-bound), a generic version of Abraxane in the United States

In January 2022, Bio Products Laboratory (BPL), announced that the National Medical Products Administration (NMPA) for China has granted BPL a license to market ALBUMINEX® 25% product to China

Competitive Landscape Analysis of Albumin Market

The global albumin market is marked by the presence of established key players such as Baxter International Inc., China Biologic Products Inc, Grifols S.A., Apotex Corp., and InVitria, among others.

For More Detailed Insights, Contact Us @ https://meditechinsights.com/contact-us/

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services.

Contact:

Ruta Halde

Associate, Medi-Tech Insights

+32 498 86 80 79

info@meditechinsights.com

[imrreport]

Global Albumin Overview Region Global Analysis and Forecast, 2022–2028.

Albumin is an important protein that is bound to plasma particles and is toxic to human health when distributed in free form. It also provides amino acids when ingested and is a major waste product outside the blood vessels. Albumin is the most abundant protein circulating in human blood. The main function of albumin is to transport endogenous and exogenous compounds.

Read more: https://introspectivemarketresearch.com/reports/albumin-market/ 

[marketresearchreports1]

Rising adoption of recombinant albumin-based drug delivery systems by pharmaceutical and biotechnology companies is one of the key factors driving the albumin (as excipient) market. For instance, in 2014, Novozymes Biopharma DK A/S announced that its albumin-based VELTIS technology is used by GlaxoSmithKline plc in the manufacturing of type II diabetes drug (Tanzeum and Eperzan) in Europe.